Philip E. Lammers
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Lung Cancer Research Studies
-
- Biosimilars and Bioanalytical Methods
Papers in
- Oncology 25
- Lung Cancer Research Studies 7
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Ira Jacobs (7 shared papers)Carmen Criscitiello (2 shared papers)Giuseppe Curigliano (2 shared papers)Josiah Ochieng (3 shared papers)Gladys N. Nangami (3 shared papers)Amos M. Sakwe (3 shared papers)Christian Jackisch (1 shared paper)Leora Horn (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (3 papers)Cancer Medicine (2 papers)Journal of the National Comprehensive Cancer Network (2 papers)Pharmaceuticals (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Philip E. Lammers
39 papers receiving 731 citations
Peers
Comparison fields: 5 of 93
- Oncology 374
- Immunology 167
- Cancer Research 116
- Radiology, Nuclear Medicine and Imaging 129
- Pulmonary and Respiratory Medicine 149
Countries citing papers authored by Philip E. Lammers
This map shows the geographic impact of Philip E. Lammers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Lammers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Lammers more than expected).
Fields of papers citing papers by Philip E. Lammers
This network shows the impact of papers produced by Philip E. Lammers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Lammers. The network helps show where Philip E. Lammers may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip E. Lammers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2019 | 53 | |
| 3 | 2018 | 46 | |
| 4 | 2018 | 45 | |
| 5 | 2016 | 44 | |
| 6 | 2015 | 38 | |
| 7 | 2021 | 37 | |
| 8 | 2017 | 37 | |
| 9 | 2017 | 33 | |
| 10 | 2015 | 31 | |
| 11 | 2013 | 29 | |
| 12 | 2018 | 27 | |
| 13 | 2018 | 27 | |
| 14 | 2020 | 24 | |
| 15 | 2016 | 22 | |
| 16 | 2014 | 20 | |
| 17 | 2016 | 20 | |
| 18 | 2016 | 19 | |
| 19 | 2015 | 16 | |
| 20 | 2005 | 14 |
About Philip E. Lammers
Philip E. Lammers is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 743 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Lung Cancer Research Studies (7 papers), Biosimilars and Bioanalytical Methods (5 papers), HER2/EGFR in Cancer Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Oncology (374 citations), Immunology (167 citations), Cancer Research (116 citations), Radiology, Nuclear Medicine and Imaging (129 citations) and Pulmonary and Respiratory Medicine (149 citations). Philip E. Lammers has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Ira Jacobs, Carmen Criscitiello, Giuseppe Curigliano, Josiah Ochieng, Gladys N. Nangami, Amos M. Sakwe, Christian Jackisch, Leora Horn, Thomas H. Cartwright and Bradley J. Monk. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Medicine, Journal of the National Comprehensive Cancer Network and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.